Company Overview

Claris Lifesciences Inc. is a pure play injectables company, involved in marketing and distribution of generic injectables in United States. The company is a wholly-owned subsidiary of Claris Lifesciences Ltd.

The company, headquartered in New Jersey, USA, has full-fledged presence to cater to the growing and unmet demands of hospitals and medical professionals for injectable products. We aim to become one of the most respected and reliable injectables companies in United States, through our focus on bringing large portfolio of high-end quality and technologically-complex injectable products.

We have full-fledged sales, marketing, and regulatory capabilities established to ensure seamless product availability and after-sales services to our esteemed customers. We have tied-up with world-class and experienced channel partners to ensure customer delight at every step of value chain.

We have a growing portfolio of injectables, with 8 molecules across 13 ANDAs. We are one of a few players to have launched technologically-advanced and complex-to-manufacture products in premix bags, PVC, and non-PVC materials.

Our other technological platforms include glass vials and ampules. We have established a strong team to address customer needs personally and provide prompt & satisfactory services. We place major emphasis on quality and technology of our products, which are manufactured at cGMP compliant facilities inspected by FDA.

What’s New?

  • New Products
  • Career
  • ANDA Approvals - Tobramycin Injection USP, Bupivacaine HCL in Dextrose Injection USP, and Flumazenil Injection USP
AwardsRecognition ProductCatalogEvents